{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:07:05Z","timestamp":1791140825794,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":76,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004426.pub2","type":"reference-entry","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T04:08:27Z","timestamp":1137730107000},"source":"Crossref","is-referenced-by-count":43,"title":["Treatment for mitochondrial disorders"],"prefix":"10.1002","author":[{"given":"PF","family":"Chinnery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Majamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD004426.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000117445","article-title":"Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study","volume":"37","author":"Chen","year":"1997","journal-title":"European Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004426.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.45.6.1193","article-title":"Short-term dichloracetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders","volume":"45","author":"DeStefano","year":"1995","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD004426.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1212\/WNL.55.11.1748","article-title":"A placebo-controlled crossover trial of creatine in mitochondrial diseases","volume":"55","author":"Klopstock","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mpd.2003.mpd0333","article-title":"The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: a double-blind randomized crossover clinical trial","volume":"142","author":"Liet","year":"2003","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004426.pub2-BIB5|cit5","first-page":"442","article-title":"Coenzyme Q10 in ophthalmoplegia plus - a double blind, cross over therapeutic trial","volume":"98 Supplement","author":"Muller","year":"1990","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"10.1002\/14651858.CD004426.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A randomized controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(96)00311-5","article-title":"Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study","volume":"148","author":"Cortelli","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1442-9071.1995.tb00164.x","article-title":"Reversible ophthalmoplegia in CPEO","volume":"23","author":"Dunlop","year":"1995","journal-title":"Australian and New Zealand Journal of Opthalmology"},{"issue":"13","key":"10.1002\/14651858.CD004426.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1073\/pnas.82.13.4513","article-title":"Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10","volume":"82","author":"Folkers","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1002\/14651858.CD004426.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000117246","article-title":"Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q","volume":"36","author":"Gold","year":"1996","journal-title":"European Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0887-8994(02)00469-1","article-title":"Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies","volume":"28","author":"Komura","year":"2003","journal-title":"Pediatric Neurology"},{"key":"10.1002\/14651858.CD004426.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004426.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1468-1331.2004.00970.x","article-title":"Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial deletions: a placebo-controlled, double-blind 31P-MRS crossover study","volume":"12","author":"Kornblum","year":"2005","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004426.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0404.1991.tb03962.x","article-title":"Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)","volume":"83","author":"Abe","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"issue":"5806","key":"10.1002\/14651858.CD004426.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"issue":"7","key":"10.1002\/14651858.CD004426.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF00873552","article-title":"Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy","volume":"242","author":"Barbiroli","year":"1995","journal-title":"Journal of Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD004426.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymgme.2004.06.009","article-title":"Chronic treatment of mitochondrial disease patients with dichloroacetate","volume":"83","author":"Barshop","year":"2004","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD004426.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.42.6.1203","article-title":"31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative peformance improvement with coenzyme Q in mitochondrial myopathies","volume":"42","author":"Bendahan","year":"1992","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004426.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-510X(93)90108-B","article-title":"Treatment of complex I deficiency with riboflavin","volume":"118","author":"Bernsen","year":"1993","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD004426.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jnnp.63.5.559","article-title":"Clinical features, investigation and management of patients with defects of mitochondrial DNA","volume":"63","author":"Chinnery","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004426.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1086\/302157","article-title":"Genetic counseling and prenatal diagnosis for mtDNA disease","volume":"63","author":"Chinnery","year":"1998","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1002\/14651858.CD004426.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P","article-title":"The epidemiology of pathogenic mitochondrial DNA mutations","volume":"48","author":"Chinnery","year":"2000","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajmg.1426","article-title":"Epidemiology and treatment of mitochondrial disease","volume":"106","author":"Chinnery","year":"2001","journal-title":"American Journal of Medical Genetics"},{"issue":"6","key":"10.1002\/14651858.CD004426.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.36.6.872","article-title":"Fatal metabolic acidosis, hyperglycemia, and coma after steroid therapy for Kearns-Sayre syndrome","volume":"36","author":"Curless","year":"1986","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004426.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1086\/302169","article-title":"Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome","volume":"63","author":"Dahl","year":"1998","journal-title":"American Journal of Human Genetics"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.75","article-title":"The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities","volume":"49","author":"Darin","year":"2001","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/883","article-title":"Nuclear power and mitochondrial disease","volume":"19","author":"DiMauro","year":"1998","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajmg.1392","article-title":"Mitochondrial DNA mutations in human disease","volume":"106","author":"DiMauro","year":"2001","journal-title":"American Journal of Medical Genetics"},{"issue":"11","key":"10.1002\/14651858.CD004426.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1073\/pnas.81.11.3529","article-title":"31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle","volume":"81","author":"Eleff","year":"1984","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1002\/14651858.CD004426.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"100-8, 10","DOI":"10.5694\/j.1326-5377.1989.tb101170.x","article-title":"Mitochondrial encephalomyopathy with corticosteroid dependence","volume":"151","author":"Gubbay","year":"1989","journal-title":"The Medical Journal of Australia"},{"issue":"6158","key":"10.1002\/14651858.CD004426.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/331717a0","article-title":"Deletion of muscle mitochondrial DNA in patients with mitochondrial myopathies","volume":"331","author":"Holt","year":"1988","journal-title":"Nature"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0404.1995.tb01697.x","article-title":"CPEO and carnitine deficiency overlapping in MELAS syndrome","volume":"92","author":"Hsu","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0022-510X(89)90112-3","article-title":"Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone","volume":"90","author":"Ihara","year":"1989","journal-title":"Journal of the Neurological Sciences"},{"issue":"5480","key":"10.1002\/14651858.CD004426.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.289.5480.782","article-title":"Role of adenine nucleotide translocator 1 in mtDNA maintenance","volume":"289","author":"Kaukonen","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1002\/14651858.CD004426.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD004426.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/BF01957508","article-title":"Therapy of complex I deficiency: peripheral neuropathy during dichloracetate therapy","volume":"154","author":"Kurlemann","year":"1995","journal-title":"European Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD004426.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.10278","article-title":"Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia","volume":"52","author":"Lamantea","year":"2002","journal-title":"Annals of Neurology"},{"issue":"9200","key":"10.1002\/14651858.CD004426.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(99)05225-3","article-title":"Mitochondrial respiratory chain disorders I: mitochondrial DNA defects","volume":"355","author":"Leonard","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004426.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archneur.1981.00510070103027","article-title":"Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in a patient with Kearns-Sayre syndrome","volume":"38","author":"Lou","year":"1981","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD004426.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/WNL.43.8.1586","article-title":"Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation","volume":"43","author":"Macmillan","year":"1993","journal-title":"Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD004426.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1006833200371","article-title":"Metabolic interventions against complex I deficiency in MELAS syndrome","volume":"174","author":"Majamaa","year":"1997","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng746","article-title":"The deoyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA","volume":"29","author":"Mandel","year":"2001","journal-title":"Nature Genetics"},{"key":"10.1002\/14651858.CD004426.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0140-6736(92)91442-B","article-title":"Remission of Leber's hereditary optic neuropathy with idebenone [letter]","volume":"340","author":"Mashima","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00041327-200020030-00006","article-title":"Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?","volume":"20","author":"Mashima","year":"2000","journal-title":"Journal of Neuro-opthalmology"},{"issue":"12","key":"10.1002\/14651858.CD004426.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1212\/WNL.43.12.2484","article-title":"Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies","volume":"43","author":"Mathews","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00401-002-0553-5","article-title":"Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease","volume":"104","author":"Mitsui","year":"2002","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1002\/14651858.CD004426.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1073\/pnas.242716699","article-title":"Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics","volume":"100","author":"Mootha","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"20","key":"10.1002\/14651858.CD004426.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM198905183202001","article-title":"Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome","volume":"320","author":"Moraes","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004426.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.braindev.2003.12.009","article-title":"Dichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS","volume":"26","author":"Mori","year":"2004","journal-title":"Brain & Development"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-3476(99)70463-4","article-title":"Respiratory chain complex III deficiency with pruritis: a novel vitamin responsive clinical feature","volume":"134","author":"Mowat","year":"1999","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD004426.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/WNL.56.7.849","article-title":"Familial cerebellar ataxia with muscle coenzyme Q10 deficiency","volume":"56","author":"Musumeci","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004426.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.20079","article-title":"POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion","volume":"55","author":"Naviaux","year":"2004","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.39.3.399","article-title":"Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study","volume":"39","author":"Nishikawa","year":"1989","journal-title":"Neurology"},{"issue":"5402","key":"10.1002\/14651858.CD004426.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.283.5402.689","article-title":"Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder","volume":"283","author":"Nishino","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/WNL.36.1.45","article-title":"Treatment of Kearns-Sayre syndrome with coenzyme Q10","volume":"36","author":"Ogasahara","year":"1986","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004426.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1073\/pnas.86.7.2379","article-title":"Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy","volume":"86","author":"Ogasahara","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1002\/14651858.CD004426.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.43.427","article-title":"Successful treatment with succinate in a patient with MELAS","volume":"43","author":"Oguro","year":"2004","journal-title":"Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004426.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1023\/B:BOLI.0000037354.66587.38","article-title":"Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases","volume":"27","author":"Panetta","year":"2004","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0960-8966(95)00020-8","article-title":"The influence of coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre syndrome and hypoparathyroidism","volume":"6","author":"Papadimitriou","year":"1996","journal-title":"Neuromuscular Disorders"},{"issue":"11","key":"10.1002\/14651858.CD004426.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1212\/WNL.42.11.2147","article-title":"MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin","volume":"42","author":"Penn","year":"1992","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD004426.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1212\/WNL.59.8.1275","article-title":"Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation","volume":"59","author":"Remes","year":"2002","journal-title":"Neurology"},{"issue":"9227","key":"10.1002\/14651858.CD004426.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(00)02531-9","article-title":"Quinone-responsive multiple respiratory chain deficiency due to widespread coenzyme Q10 deficiency","volume":"356","author":"Rotig","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng751","article-title":"Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy","volume":"29","author":"Saada","year":"2001","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1002\/14651858.CD004426.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1022685929755","article-title":"Mitochondrial DNA mutations and pathogenesis","volume":"29","author":"Schon","year":"1997","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"20","key":"10.1002\/14651858.CD004426.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.86.20.7952","article-title":"Spontaneous Kearn-Sayre\/chronic external ophthalmoplegia plus syndromes associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy","volume":"86","author":"Shoffner","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Pt 8","key":"10.1002\/14651858.CD004426.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/brain\/awg170","article-title":"Minimum birth prevalence of mitochondrial respiratory chain disorders in children","volume":"126","author":"Skladal","year":"2003","journal-title":"Brain"},{"issue":"5","key":"10.1002\/14651858.CD004426.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1212\/WNL.48.5.1238","article-title":"Mitochondrial encephalomyopathy with coenzyme Q10 deficiency","volume":"48","author":"Sobreira","year":"1997","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/90058","article-title":"Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localised in mitochondria","volume":"28","author":"Spelbrink","year":"2001","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1002\/14651858.CD004426.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.1050","article-title":"Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects","volume":"50","author":"Taivassalo","year":"2001","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004426.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1212\/WNL.52.4.854","article-title":"Creatine monohydrate increases strength in patients with neuromuscular disease","volume":"52","author":"Tarnopolsky","year":"1999","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004426.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/humrep\/15.suppl_2.79","article-title":"In-vitro genetic modification of mitochondrial function","volume":"15","author":"Taylor","year":"2000","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD004426.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajmg.1380","article-title":"Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options","volume":"106","author":"Thorburn","year":"2001","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/90034","article-title":"Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions","volume":"28","author":"Goethem","year":"2001","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1002\/14651858.CD004426.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00763096","article-title":"Mitochondrial DNA mutations in diseases of energy metabolism","volume":"26","author":"Wallace","year":"1994","journal-title":"Journal of Bioenergetics & Biomembranes"},{"issue":"5407","key":"10.1002\/14651858.CD004426.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in mouse and man","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1002\/14651858.CD004426.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1212\/WNL.38.9.1339","article-title":"Deletions of mitochondrial DNA in Kearns-Sayre syndrome","volume":"38","author":"Zeviani","year":"1988","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004426.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004426.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:35:03Z","timestamp":1628544903000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004426.pub2"}},"subtitle":[],"editor":[{"given":"PF","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,1,25]]},"references-count":76,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004426.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004426.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,1,25]]}}}